Oncology Impact Fund (Cayman) Management L.P., 10% Owner at Harpoon Therapeutics, Inc. (HARP), sold 447 shares at $14.00 ($6K) on 2019-02-12, disclosed to the SEC on 2019-02-14.
Open-market sale of $6k HARP by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ITOS | SELL | 2021-11-24 | $8.9M | — | Filing → |
| ITOS | SELL | 2021-10-18 | $1.6M | — | Filing → |
| ITOS | SELL | 2021-10-12 | $4.6M | — | Filing → |